A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
55–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects must have Alzheimer's dementia with a Mini Mental State Examination score between 18-26, inclusive.
Subjects must have a reliable caregiver.
Subjects must be on Aricept
Memantine is allowed if subjects are on a stable dose
Subjects must be in reasonably good health, based on medical history, physical examination, vital signs, and ECG, with no serious or unstable disease within the past 3 months.
You may not be if
Subjects with clinically significant heart disease cannot participate.
Subjects with a past or current history of seizures cannot participate.
